Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

BACKGROUND: Data that directly associate utilization of novel systemic therapies with survival trends in metastatic breast cancer (MBC) are limited. In the setting of de novo MBC, large registry analyses cite positive temporal trends in survival, but the extent to which advances in systemic therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Sumanta K, Dehaven, Mary, Nelson, Rebecca A, Onami, Susan, Hsu, JoAnn, Waliany, Sarah, Kruper, Laura, Mortimer, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526502/
https://www.ncbi.nlm.nih.gov/pubmed/23020297
http://dx.doi.org/10.1186/1471-2407-12-435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526502/
https://www.ncbi.nlm.nih.gov/pubmed/23020297
http://dx.doi.org/10.1186/1471-2407-12-435

Ejemplares similares